Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ultupharma AB
AB
Active
Org 5590282892
Södra Rudbecksgatan 13, 752 36
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2015 · 10 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Ultupharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-1M
-3M
-4M
-5M
-4M
2020
-3M
+25%
2021
-1M
+67%
2022
0M
+100%
2023
-1M
-100%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
300
50
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−3 706
−2 654
−525
−356
−642
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−3 706
−2 654
−525
−356
−642
Net financials
—
−1
—
—
—
Profit before tax
−3 706
−2 655
−525
−356
−642
Tax
−0
−0
−0
−0
−0
Net profit
−3 706
−2 655
−525
−356
−642
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
3 407
783
197
208
200
Equity
2 453
590
165
159
117
Long-term debt
0
0
0
0
0
Short-term debt
954
192
31
49
83
Total debt
954
192
31
49
83
Financial ratios
5-year trend
EBITDA margin
-64200000.0%
This company
15.8%
Market median
-406329214% vs market
2020
2024
Equity ratio
58.5%
This company
38.2%
Market median
+53% vs market
2020
2024
Return on equity
-548.7%
This company
18.4%
Market median
-3082% vs market
2020
2024
Net profit margin
-64200000.0%
This company
8.1%
Market median
-792592693% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Ultupharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
